A61P 5 - Drugs for disorders of the endocrine system

Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
11/2006
11/07/2006	CA2416879C Methods of treating cancer and the pain associated therewith using endothelin antagonists
11/02/2006	WO2006116526A2 Polymorph form ii of tanaproget
11/02/2006	WO2006115187A1 Pharmaceutical for prevention or treatment of bone metabolic disease
11/02/2006	US20060247264 Modulators of the Glucocorticoid Receptor
11/02/2006	US20060247261 Pyrimidine compounds
11/02/2006	US20060247226 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
11/02/2006	US20060247219 Specific glucocorticosteriod compound having anti-inflamatory activity
11/02/2006	US20060246110 Sustained release pharmaceutical composition
11/02/2006	EP1717230A1 Fused-ring 4-oxopyrimidine derivative
11/02/2006	EP1716851A1 Thioamides and salts thereof and cytokine production inhibitors containing both
11/02/2006	EP1716167A1 Cell surface marker
11/02/2006	EP1716166A2 17-methylene- or 17-spiro-cyclopropane 7-substituted estra-1,3,5(10)-triene derivatives with anti-estrogenic activity
11/02/2006	EP1716110A1 Androgen receptor modulators
11/02/2006	EP1715895A2 Chemically-modified human growth hormone receptor antagonist conjugates
11/02/2006	EP1715887A1 N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
11/02/2006	EP1715857A1 Amidine derivatives for treating amyloidosis
11/02/2006	EP1401801B1 Selective androgen receptor modulators and methods of use thereof
11/02/2006	EP1214295B1 Hydroxyacetamidobenzenesulphonamide derivatives
11/02/2006	EP0873361B1 Crystals of the ligand-binding domain of the thyroid hormone receptor complexed to a ligand
11/02/2006	CA2603807A1 Polymorph form ii of tanaproget
11/01/2006	CN1853505A Edible ginkgo pollen
11/01/2006	CN1282456C Paroxetine control-released composite
10/2006
10/31/2006	US7129270 Antiinflammatory agents
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129241 Pyridazine derivatives
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them
10/31/2006	US7129236 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/31/2006	US7129231 Regulation of intracellular glucocorticoid concentrations
10/31/2006	CA2230672C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities
10/26/2006	WO2006112737A1 Vesiculins
10/26/2006	WO2006112331A1 Novel condensed pyrrole derivative
10/26/2006	WO2006111776A2 Pharmaceutical composition comprising serum obtained from a naive mammal
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	US20060241112 Kinase inhibitors
10/26/2006	US20060241030 Irs modulators
10/26/2006	US20060241019 Long lasting insulin derivatives and methods thereof
10/26/2006	US20060240023 Apoptosis-associated protein and use thereof
10/26/2006	US20060240015 Recombinant antibody against human insulin-like growth factor
10/25/2006	EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006	EP1714643A1 Sustained release preparation
10/25/2006	EP1713820A1 Selective estrogen receptor modulators
10/25/2006	EP1713770A1 Selective estrogen receptor modulators
10/25/2006	EP1713463A2 Reelin deficiency or dysfunction and methods related thereto
10/25/2006	EP1392689B1 Tri- and tetraaza-acenaphthylen derivatives as crf receptor antagonists
10/25/2006	EP1383511B1 Calcilytic compounds
10/25/2006	EP1219632B1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds
10/25/2006	CN1850168A Water-lily-powder composition with function of compensating estrogen
10/25/2006	CN1281601C Bipyridyl derivatives as a highly selective cyclooxygenase-2 inhibitor
10/25/2006	CN1281598C Compounds and methods for modulation of estrogen receptors
10/25/2006	CN1281217C Use of activated carbon in oral medicinal preparation for hyperthyroidism
10/24/2006	US7126012 Has affinity for melatonin receptors and/or selectivity for melatoninergic receptors; antiinflammatory and anticarcinogic agents
10/24/2006	US7125990 For treatment of depression, anxiety, affective disorders, feeding disorders, post-traumatic stress disorder, headache, drug addiction, inflammatory disorders, drug or alcohol withdrawal symptoms
10/24/2006	US7125985 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
10/24/2006	US7125900 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/24/2006	US7125873 Beta-amino tetrahydroimidazo (1, 2-a) pyrazines and tetrahydrotrioazolo (4, 3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
10/24/2006	US7125863 Inhibitors of dipeptidyl peptidase IV
10/24/2006	CA2158400C Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxybenzo[b]thiophenes
10/20/2006	CA2603295A1 Use of ghrelin for the treatment of hyperthyroidism
10/19/2006	WO2006109846A1 Triazole derivative and the use thereof
10/19/2006	WO2006108719A1 Method of treating or preventing type-2 diabetes
10/19/2006	WO2006108699A1 Indazoles as glucocorticoid receptor ligands
10/19/2006	WO2006108667A2 Method of treatment using gh antagonist and somatostatin agonist
10/19/2006	US20060235078 Use of triterpenes of given formula based on a picene ring structure; side effect reduction such as of insulin resistance over current antidiabetes agents
10/19/2006	US20060235023 Inhibitors of macrophage migration inhibitory factor and methods for indentifying the same
10/19/2006	US20060235011 N-cyclopropylmethyl-N-7-[2,6-dimethoxy-4-(methoxymethyl)phenyl]-2-ethylpyrazolo[1,5-a]pyridin-3-yl-N-tetrahydro-2H-4-pyranylmethylamine; depressive symptom, mania, anxiety, general anxiety disorder, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, Tourette's syndrome
10/19/2006	US20060234914 Fragments of proinsulin c-peptide
10/19/2006	US20060233841 Implantable gel compositions and method of manufacture
10/19/2006	US20060233804 IGF antagonist peptides
10/19/2006	CA2604381A1 Use of growth hormone antagonist and somatostatin agonist
10/19/2006	CA2604077A1 Method of treating or preventing type-2 diabetes
10/18/2006	EP1711477A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1
10/18/2006	EP1339714B1 Novel sulfonamide-substituted pyrazolopyridine derivatives
10/18/2006	EP1283828B1 Novel polymorph v of torasemide
10/18/2006	EP1141286B1 Cytokine receptor chain
10/18/2006	EP1042468B1 Low-voltage activated calcium channel compositions and methods
10/18/2006	CN1849330A Specific glucocorticosteroid compound having anti-inflammatory activity
10/18/2006	CN1849126A 17-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
10/18/2006	CN1279981C 5-CNAC as oral delivery agent for parathyroid hormone fragments
10/18/2006	CN1279975C Inducer of blood vessel neogenesis
10/18/2006	CN1279951C Pure Chinese traditional medicine capsule for treating hyperthyroidism and simple goiter
10/17/2006	US7122565 Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors
10/17/2006	US7122532 Regulation of intracellular glucocorticoid concentrations
10/17/2006	US7122531 Regulation of intracellular glucocorticoid concentrations
10/17/2006	US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006	CA2447405C Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/12/2006	WO2006106812A1 Propane-1,3-dion derivative or salt thereof
10/12/2006	WO2006105615A1 Buccal delivery system
10/12/2006	WO2006066868A3 Sustained release formulation comprising bisphosphonate
10/12/2006	US20060229343 Pyrrolidine oxadiazole-and thiadiazole oxime derivatives being oxytocin receptor antagonists
10/12/2006	US20060229340 Composition for improving cognition and memory
10/12/2006	US20060229333 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors
10/12/2006	US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
10/12/2006	US20060228353 PTH1R and PTH3R receptors, methods and uses thereof
10/12/2006	CA2603649A1 Buccal delivery system
10/11/2006	EP1709071A1 Glucagon-like peptide-1 analogs with long duration of action
10/11/2006	EP1709061A1 Di-steroidal prodrugs of ethinyl estradiol
10/11/2006	EP1709023A1 Selective estrogen receptor modulators
10/11/2006	EP1709022A1 Selective estrogen receptor modulators
10/11/2006	EP1363903B1 Indole derivatives and their use as gnrh antagonists

1 ... 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 ... 290